Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 11 — Sustainable Cities and Communities
This track focuses on the latest innovations in pharmaceutical chemistry, emphasizing novel methodologies and techniques in drug synthesis. Participants will explore the implications of these advancements on drug efficacy and safety.
This session will delve into cutting-edge strategies in drug design, including structure-based drug design and computer-aided drug discovery. Attendees will discuss the integration of computational tools in the drug development process.
This track highlights the role of medicinal chemistry in the development of therapeutic agents, focusing on the chemical properties that influence biological activity. Participants will analyze case studies of successful drug candidates.
This session will explore the principles of pharmacology and their application in therapeutic settings, including drug interactions and adverse effects. Discussions will center on optimizing drug therapy for patient-centered care.
This track will examine emerging trends in drug discovery, including high-throughput screening and biomarker identification. Participants will evaluate the impact of these trends on the pharmaceutical industry and patient outcomes.
This session will address the challenges faced in formulation science, including stability and bioavailability issues. Innovative approaches to formulation design will be discussed to enhance drug delivery systems.
This track will cover various research methodologies employed in pharmaceutical sciences, including in vitro and in vivo studies. Attendees will gain insights into best practices for conducting robust pharmaceutical research.
This session will focus on the role of clinical pharmacy in optimizing medication management and improving patient outcomes. Discussions will include interdisciplinary collaboration and the pharmacist's role in healthcare teams.
This track will explore the intersection of chemical biology and drug development, highlighting how biological insights can inform chemical design. Participants will discuss case studies that illustrate successful collaborations between disciplines.
This session will examine the latest advancements in pharmaceutical engineering, focusing on manufacturing processes and quality control. Participants will discuss how engineering principles can enhance drug production efficiency.
This track will address the challenges of pharmaceutical innovation within the regulatory landscape, including compliance and approval processes. Discussions will focus on strategies to navigate regulatory hurdles while fostering innovation.
SNRI maintains uninterrupted academic processes in the current global situation. Participants can engage and publish through online and blended conference formats.
PLEASE READ: CLOSING ENABLED IN 20S